Danqing Wu

Danqing Wu's work experience includes serving as a Director of Biologics Discovery at EpimAb Biotherapeutics, Inc. since 2017. Prior to that, they worked at Novartis Institutes for BioMedical Research (NIBR) as an Investigator II from September 2015 to December 2016, an Investigator I from September 2013 to August 2015, and as a Scientist from June 2010 to August 2013. Before joining NIBR, Wu was a Scientist at GlaxoSmithKline from April 2008 to May 2010 and at Epitomics from 2005 to 2008.

Danqing Wu completed their Bachelor of Biochemical Engineering degree from Zhejiang University in the years 1998 to 2002. Danqing then pursued their Master of Biochemical Engineering from the same university from 2002 to 2005. Unfortunately, the specific field of study for both degrees is not provided.